The Shifting Landscape of Accounting Oversight

President Donald Trump wants to bring additional drug manufacturing to the United States and has threatened tariffs on imported medicine. The U.S. relies heavily on imports for low-cost generics, and building up domestic supply chain capacity could be tricky. We'll map out drug manufacturing and explore what it'd take to reshore drug supplies. But first: oil giants are eager to drill off the coast of Guyana, and the boss of an obscure regulatory agency is stepping down.